Last reviewed · How we verify
NCT04916834
Impact of Severe Acute Respiratory Syndrome (SARS-CoV-2/COVID-19) Related Pneumonia on Lung Function and Structure.
trial in Covid19 in 100 participants. Status unknown.
30 November 2023
Quick facts
| Lead sponsor | National Institute for Tuberculosis and Lung Diseases, Poland |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 30 August 2020 |
| Primary completion | 30 November 2023 |
| Estimated completion | 30 November 2024 |
| Sites | 1 location across Poland |
Conditions studied
- Covid19 — all drugs for Covid19 →
- SARS-CoV Infection — all drugs for SARS-CoV Infection →
- Pulmonary Function — all drugs for Pulmonary Function →
- Pneumonia, Viral — all drugs for Pneumonia, Viral →
Sponsor
National Institute for Tuberculosis and Lung Diseases, Poland
Who can join
Adults 18 to 100, any sex, with Covid19 or SARS-CoV Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective study in a group of patients with COVID-19 pneumonia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04916834
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Other National Institute for Tuberculosis and Lung Diseases, Poland trials
Trials by the same sponsor.
- NCT05752708 — Perioperative Anxiety Risk Factors in Parents of Children Undergoing Thoracic Surgery · recruiting
- NCT06964074 — PEP and O-PEP Device for Nebulization in Cystic Fibrosis · NA · active not recruiting
- NCT04036721 — Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis · Phase 4 · suspended
- NCT04509921 — Adjustment of Asthma Treatment in Children Based on an Indirect Hyperresponsiveness Test · NA · completed
- NCT03894475 — Non-inferiority of Portable Versus Desktop Spirometry · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04916834 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Institute for Tuberculosis and Lung Diseases, Poland
- Last refreshed: 23 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04916834.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing